Skip to main content

Close

Search

Donate
Cerca
Menu

About us
Research and innovation
Scientific career
Living Lab for Health
News
Collaborate

Who we are
Organigram
Team
Board
Executive committee
International scientific committee
Ethics committee and communication channel
Director
Transparency
Equality, diversity and inclusion
Contact

Research groups
Strategic lines
Publications
Projects
Clinical studies
Patents
Spin-offs
Scientific reports
Scientific and technical services
RRI

Training in biomedical sciences
HRS4R
Work with us
IrsiCaixa Alumni Network

About the Lab
Methodology
Services
Projects
Publications and resources

Latest news
Press
Outreach

About us
Research and innovation
Scientific career
Living Lab for Health
News
Collaborate

twitter
linkedin
instagram
youtube
tiktok

Transparency
Press
Contact us

ca
es
en

Intranet

Donate
Cerca
Menu

Publication

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.

See all publications

Breadcrumb

Home
Research and innovation
Publications

Journal

Frontiers in pharmacology

Year

2024

Read abstract online

DOI

10.3389/fphar.2024.1331648

Irsicaixa authors

Fernando Laguía Nueda

Research group

Retrovirology and Clinical Studies (GREC)

International reference institute, leader in the research for the eradication of HIV/AIDS and related diseases.

Hospital Germans Trias i Pujol.
2nd floor, Maternity building
Ctra del Canyet, s/n 08916 Badalona (Barcelona)

(+34) 93 465 63 74

Subscribe to our newsletter

I accept the sending of communications about IrsiCaixa activities, promotions and scientific and educational innovations.

Disclaimer and conditions of use
Cookie Policy
Privacy policy
Communication channel

Not available in

This is not available in . You can go to the translated versions in these languages: